Charles Schwab Investment Management Inc Avrobio, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.75 - $1.33 $35,164 - $62,358	-46,886 Reduced 55.74%	37,231 $35,000
Q1 2022 May 13, 2022	SELL	$1.29 - $4.04 $17,244 - $54,006	-13,368 Reduced 13.71%	84,117 $112,000
Q4 2021 Feb 11, 2022	BUY	$3.45 - $6.05 $19,330 - $33,898	5,603 Added 6.1%	97,485 $376,000
Q3 2021 Nov 16, 2021	SELL	$5.53 - $9.28 $865,511 - $1.45 Million	-156,512 Reduced 63.01%	91,882 $513,000
Q2 2021 Aug 16, 2021	BUY	$7.84 - $12.6 $219,896 - $353,404	28,048 Added 12.73%	248,394 $2.21 Million
Q1 2021 May 17, 2021	SELL	$10.54 - $19.3 $6,492 - $11,888	-616 Reduced 0.28%	220,346 $2.8 Million
Q4 2020 Feb 16, 2021	BUY	$12.79 - $17.1 $257,002 - $343,607	20,094 Added 10.0%	220,962 $3.08 Million
Q3 2020 Nov 13, 2020	BUY	$12.99 - $19.41 $249,589 - $372,943	19,214 Added 10.58%	200,868 $2.62 Million
Q2 2020 Aug 14, 2020	BUY	$12.19 - $22.96 $368,771 - $694,585	30,252 Added 19.98%	181,654 $3.17 Million
Q1 2020 May 15, 2020	BUY	$10.08 - $27.21 $200,037 - $539,982	19,845 Added 15.08%	151,402 $2.36 Million
Q4 2019 Feb 07, 2020	BUY	$13.05 - $21.88 $6,224 - $10,436	477 Added 0.36%	131,557 $2.65 Million
Q3 2019 Nov 08, 2019	BUY	$14.12 - $23.44 $1.04 Million - $1.73 Million	73,946 Added 129.43%	131,080 $1.85 Million
Q2 2019 Aug 09, 2019	BUY	$13.21 - $27.29 $170,158 - $351,522	12,881 Added 29.11%	57,134 $929,000
Q1 2019 May 14, 2019	BUY	$12.46 - $22.05 $143,115 - $253,266	11,486 Added 35.05%	44,253 $976,000
Q4 2018 Feb 14, 2019	SELL	$15.43 - $32.7 $10,291 - $21,810	-667 Reduced 1.99%	32,767 $546,000
Q3 2018 Nov 13, 2018	BUY	$26.95 - $52.7 $901,046 - $1.76 Million	33,434 New	33,434 $1.74 Million

Others Institutions Holding AVRO

# of Institutions

Shares Held

559K

Call Options Held

Put Options Held

Terrapin Asset Management, LLC Miami, FL

559K
Shares

$0
0.98% of portfolio

View Full List

About AVROBIO, Inc.

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

More about AVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account